Health Boards
›
Psoriasis In The News
Germany says Cosentyx shows no added benefit for psoriatic arthritis.
|
Germany says Cosentyx shows no added benefit for psoriatic arthritis.
|
Wed-23-03-2016, 23:15 PM
Politics as usual. The manufacturer doesn't need to spend millions USD to figure out where consentyx stands with PsA. It's no better than the TNfs if you consider the current standard. However, there isn't a drug that has statistically shown superiority over TNFs. What we do know is the TNFs have a high rate of failure or reduced benefit over a prolonged period of time. It's nice to give another option for those people.
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Sotyktu accepted for review in psoriatic arthritis | Fred | 0 | 324 |
Tue-22-07-2025, 11:41 AM Last Post: Fred |
|
|
Ilumya / Ilumetri phase 3 for psoriatic arthritis | Fred | 0 | 257 |
Tue-22-07-2025, 11:24 AM Last Post: Fred |
|
|
Spyre SPY072 for psoriatic arthritis phase 1 | Fred | 1 | 557 |
Thu-17-07-2025, 20:15 PM Last Post: Caroline |
|
|
Psoriatic arthritis and family history | Fred | 0 | 292 |
Tue-15-07-2025, 13:09 PM Last Post: Fred |
|
|
Potential microRNA biomarkers for psoriatic arthritis | Fred | 1 | 327 |
Wed-02-07-2025, 19:29 PM Last Post: Caroline |
